Moderna has given out the primary doses of an mRNA-based influenza vaccine to individuals in an early-phase medical trial, the corporate introduced Wednesday. Moderna in the end plans to check the vaccine on about 180 other people within the Section half of randomized, stratified, observer-blind trial. The trial will take …
Read More »